These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8439985)

  • 1. T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.
    Lando PA; Dohlsten M; Hedlund G; Akerblom E; Kalland T
    Cancer Immunol Immunother; 1993; 36(4):223-8. PubMed ID: 8439985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells.
    Dohlsten M; Sundstedt A; Björklund M; Hedlund G; Kalland T
    Int J Cancer; 1993 May; 54(3):482-8. PubMed ID: 8509223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
    Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
    Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies and superantigens: a novel therapeutic approach.
    Kalland T; Dohlsten M; Lind P; Sundstedt A; Abrahmsén L; Hedlund G; Björk P; Lando PA; Björklund M
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):37-47. PubMed ID: 8258993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of human colon cancer by antibody-targeted superantigens.
    Dohlsten M; Lando PA; Björk P; Abrahmsén L; Ohlsson L; Lind P; Kalland T
    Cancer Immunol Immunother; 1995 Sep; 41(3):162-8. PubMed ID: 7553685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
    Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A3--a novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells.
    Tordsson J; Lavasani S; Ohlsson L; Karlström P; Svedberg H; Abrahmsén L; Brodin T
    Int J Cancer; 2000 Aug; 87(4):559-68. PubMed ID: 10918198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
    Lando PA; Hedlund G; Dohlsten M; Kalland T
    Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
    Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
    Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
    Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
    Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of superantigens.
    Kalland T; Dohlsten M; Abrahmsén L; Hedlund G; Björk P; Lando PA; Sundstedt A; Akerblom E; Lind P
    Cell Biophys; 1993; 22(1-3):147-64. PubMed ID: 7889537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
    Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
    J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-reactive superantigens suppress tumor growth in humanized SCID mice.
    Lando PA; Dohlsten M; Ohlsson L; Kalland T
    Int J Cancer; 1995 Aug; 62(4):466-71. PubMed ID: 7635573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
    Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.